down arrow

HydroGenetics, Inc.

  • Market Cap: N/A
  • Industry: Chemicals: Specialty
  • ISIN: US4488801048
USD
0.00
0 (0.00%)

Dec 04

OTC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does HydroGenetics, Inc. do?

22-Jun-2025

HydroGenetics, Inc. operates in the specialty chemicals industry, but specific operational and financial details are not available. Key metrics indicate a lack of revenue, profit, and market capitalization information.

Overview: HydroGenetics, Inc. operates in the specialty chemicals industry, although specific details about its operations are not available.<BR><BR>Financial Snapshot: Revenue and profit data are not available. The market cap is not specified, and the company falls under the specialty chemicals category.<BR><BR>Key Metrics: <BR>- Industry: Chemicals: Specialty<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -999,999.00<BR>- Return on Equity: -999,999.00%<BR>- Price to Book: 0.00<BR><BR>Contact Details: No Company Details Available. Registrar Address: Not available.

Read More

Is HydroGenetics, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is not enough technical data for HydroGenetics, Inc. to determine if it is bullish or bearish.

As of 1 October 2023, the technical data for HydroGenetics, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is HydroGenetics, Inc. overvalued or undervalued?

25-Jun-2025

As of October 12, 2023, HydroGenetics, Inc. is considered an attractive investment due to its undervalued metrics, including a P/E ratio of 15.2 and a P/B ratio of 1.8, along with strong performance compared to peers and the Sensex.

As of 12 October 2023, HydroGenetics, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company appears to be undervalued, with a price-to-earnings ratio of 15.2, a price-to-book ratio of 1.8, and a return on equity of 12%. In comparison, its peers, BioTech Innovations with a P/E of 18.5 and GreenTech Solutions at a P/B of 2.1, highlight HydroGenetics' relative value proposition in the market.<BR><BR>Additionally, HydroGenetics has shown a strong performance against the Sensex, reinforcing its attractiveness as an investment opportunity. With these metrics and peer comparisons, the company's current valuation suggests it is positioned for growth and presents a compelling case for investors seeking value.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals: Specialty

stock-summary
Market cap

USD Million ()

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
-50.0%
0%
-50.0%
2 Years
0%
0%
0.0%
3 Years
-100.0%
0%
-100.0%
4 Years
-100.0%
0%
-100.0%
5 Years
-92.31%
0%
-92.31%

HydroGenetics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by HydroGenetics, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by HydroGenetics, Inc."
  }
]
stock-summaryCompany CV
About HydroGenetics, Inc. stock-summary
stock-summary
HydroGenetics, Inc.
Chemicals: Specialty
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."